Safety and Performance of New 2-piece Ostomy Product Concept Compared With SenSura Click in Subjects With Ileostomy

NCT ID: NCT01800890

Last Updated: 2014-08-06

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

31 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-02-28

Study Completion Date

2013-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of the current clinical investigation is to evaluate the performance and safety of new 2-piece ostomy product concepts.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The new products have been developed to reduce the degree of leakage and other problems related to ostomy appliances in people with a stoma.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Subjects With an Ileostomy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Treatment sequence 1

Subjects randomised to Treatment sequence 1 will test three different products:

1. Coloplast A
2. Coloplast B
3. SenSura Click

The subjects test the three test products in a randomized order: ABS; BSA, SAB

Group Type OTHER

Coloplast A

Intervention Type DEVICE

Coloplast A is a newly developed 2-piece ostomy appliance

Coloplast B

Intervention Type DEVICE

Coloplast B is a newly developed 2-piece ostomy appliance

SenSura Click

Intervention Type DEVICE

The comparator product is the commercial and CE-marked SenSura Click (2-piece) manufactured by Coloplast A/S.

Treatment sequence 2

Subjects randomised to Treatment sequence 2 will test three different products:

1. Coloplast C (C)
2. Coloplast B (B)
3. SenSura Click (S)

The subjects test the three test products in a randomized order: CBS; BSC, SCB

Group Type EXPERIMENTAL

Coloplast B

Intervention Type DEVICE

Coloplast B is a newly developed 2-piece ostomy appliance

Coloplast C

Intervention Type DEVICE

Coloplast C is a newly developed 2-piece ostomy appliance

SenSura Click

Intervention Type DEVICE

The comparator product is the commercial and CE-marked SenSura Click (2-piece) manufactured by Coloplast A/S.

Treatment sequence 3

Subjects randomised to Treatment sequence 3 will test three different products:

1. Coloplast A (A)
2. Coloplast C (C)
3. SenSura Click (S)

The subjects test the three test products in a randomized order: ACS; CSA, SAC

Group Type EXPERIMENTAL

Coloplast A

Intervention Type DEVICE

Coloplast A is a newly developed 2-piece ostomy appliance

Coloplast C

Intervention Type DEVICE

Coloplast C is a newly developed 2-piece ostomy appliance

SenSura Click

Intervention Type DEVICE

The comparator product is the commercial and CE-marked SenSura Click (2-piece) manufactured by Coloplast A/S.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Coloplast A

Coloplast A is a newly developed 2-piece ostomy appliance

Intervention Type DEVICE

Coloplast B

Coloplast B is a newly developed 2-piece ostomy appliance

Intervention Type DEVICE

Coloplast C

Coloplast C is a newly developed 2-piece ostomy appliance

Intervention Type DEVICE

SenSura Click

The comparator product is the commercial and CE-marked SenSura Click (2-piece) manufactured by Coloplast A/S.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Have given written informed consent and signed letter of authority form.
2. Be at least 18 years of age and have full legal capacity.
3. Be able to handle the appliances themselves
4. Have an ileostomy with a diameter between 15 and 40 mm.
5. Have had their ostomy for at least three months.
6. Use minimum 1 baseplate every third day.
7. Currently use 2-piece flat mechanical coupling product with open bag and a coupling size in the inter val of 43-55mm (both extremes included)
8. Must be able to use custom cut product
9. Accept to test three 2-piece products within the study.
10. Negative result of a pregnancy test for women of childbearing age.

Exclusion Criteria

1. Use irrigation during the study (flush the stoma with water).
2. Currently receiving or have within the past 2 months received radio- and/or chemotherapy.
3. Currently receiving or have within the past month received local or systemic steroid treatment in the peristomal area.
4. Are pregnant or breastfeeding.
5. Participating in other interventional clinical investigations or have previously participated in this investigation.
6. More than three days wear time as usual change pattern.
7. Currently using ostomy belt
8. Currently using extended wear product (Sensura Xpro, Assura TERA, Dansac NovaLife X3, Hollister Flextend, Convatec Durahesive)
9. Have a loop ileostomy
10. Known hypersensitivity towards any of the test products
11. Suffer from peristomal skin problems that preclude participation in the investigation (assessed by the investigation nurse)
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Coloplast A/S

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Daniel Carter, MSc

Role: STUDY_CHAIR

Coloplast A/S

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Coloplast A/S

Humlebæk, , Denmark

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Denmark

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CP234

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.